Exome Asset Management »

Soleno Therapeutics shares owned by Exome Asset Management

Quarter-by-quarter ownership of Soleno Therapeutics shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $328k 7.1k 46.13
2025-03-31 $275 11k 0.03

More positions owned by Exome Asset Management

Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Guardant Health (GH)
Ionis Pharmaceuticals (IONS)
Eli Lilly & Co. (LLY)
Cytokinetics Com New (CYTK)
Wave Life Sciences SHS (WVE)
Vera Therapeutics Cl A (VERA)
Bridgebio Pharma (BBIO)
Anthem (ELV)
Astrazeneca Sponsored Adr
Jazz Pharmaceuticals Shs Usd (JAZZ)
Natera (NTRA)
Immunovant (IMVT)
Universal Hlth Svcs CL B (UHS)

View all positions for Exome Asset Management

Top funds holding Soleno Therapeutics

Simplex Trading
Group One Trading
IMC-Chicago
Exome Asset Management

View all funds holding Soleno Therapeutics